Pricing Log in Create free account

Lisata Therapeutics, Inc. (LSTA) vs Psyence Biomedical Ltd. (PBM)

Lisata Therapeutics, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Lisata Therapeutics, Inc. and Psyence Biomedical Ltd. are of similar size ($11.2M and $10.7M). Lisata Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Across the 8 metrics below, Psyence Biomedical Ltd. leads on 5 and Lisata Therapeutics, Inc. on 3.

Valuation

Metric LSTA PBM Biotechnology median
P/E n/m 0.13 10.60
P/S 0.61 n/m 9.40
P/B 1.16 0.06 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.91 0.66
EV/Sales 0.14 n/m 9.02
Earnings yield (160.78%) 742.35% (32.88%)
Free cash flow yield (132.98%) (1,121.21%) (23.13%)

Profitability

Metric LSTA PBM Biotechnology median
Gross margin 0.49% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.66%) (23.52%) (51.96%)
Return on assets (80.81%) (6.74%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSTA PBM Biotechnology median
Revenue growth (TTM) (24.67%) — 6.76%
EPS growth (last fiscal year) 20.42% (138.35%) 29.88%
Revenue growth, 5-year CAGR (20.28%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LSTA PBM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.69 8.09 4.97
Net debt to EBITDA 0.88 1.20 1.01

Dividend

Metric LSTA PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LSTA PBM Biotechnology median
Market cap 10.71m 11.21m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack